The month of June 2017 had several position changes in institutional finance. A prominent investor's son stepped down from his father’s family office to set up his own fund. An ex-Barclays' chief executive resigned from BlackRock’s board over fraud charges. A top venture capital firm appointed a new general partner that is expected to lead their big push into healthcare IT. Here are the top institutional investment and GP job changes in June:
Robert Soros, the eldest son of George Soros, stepped down as deputy chairman and president at Soros Fund Management. He intends on setting up Soros Capital, which focuses on illiquid investments including venture capital. Soros resigned from those roles and stepped down from day-to-day management in late June.
Clara Miller, director and president of the F.B. Heron Foundation, announced in June that her role at the foundation will change in 2018. She will assume a new leadership position as president emerita at the foundation, effective December 31. An immediate replacement was not named.
The Saint Paul & Minnesota Community Foundations welcomed Wei Huang as the organizations new chief investment officer early June 2017. Huang filled the role of Jack Pohl, who retired in February after 32 years of service. Huang offers a wealth of experience in capital markets, portfolio construction and management, asset allocation theory and modeling, alternative assets, benchmark analysis and performance measurement.
John Varley, former chief executive at Barclays, resigned from BlackRock’s board of directors in June. Varley is one of four former Barclays directors facing charges by the UK's Serious Fraud Office. The charges include conspiracy to commit fraud and the provision of unlawful financial assistance, during the 2008 financial crisis.
Bill Gurley, general partner at Benchmark, left Uber’s board of directors as of June 22, 2017. Gurley's departure came one day after the resignation of CEO Travis Kalanick following the months of controversy over its corporate culture. Matt Cohler, general partner at Benchmark, will replace him.
Jorge Conde, co-founder of biotech software company Knome and CFO at Syros Pharmaceuticals, joined Andreessen Horowitz. He was appointed general partner at the venture capital firm and will officially start in September 2017. Andreessen Horowitz is making an even bigger push into healthcare IT, bringing aboard serial entrepreneur Conde.
John Paulson, billionaire hedge fund manager at Paulson & Co., joined Valeant Pharmaceuticals International's board of directors in mid June. Paulson became the 11th member on the board.
Eric Hazard, a 20-year financial technology and communications veteran, joined Vested Ventures. He was appointed CEO in June 2017. Vested Ventures was established in February 2017 to make strategic investments and provide communications services to startup companies in the finance and technology space.
Check out Trusted Insight's People Moves roundups from previous months here.